Despite established purification steps and unit operations in the manufacturing workflow, the technique and raw materials used to synthesize mRNA remain highly variable. This lack of standardization and cost-effective techniques for manufacturing and analytics for product characterization create challenges when it comes to establishing CMC principles for mRNA-based products.